ISRCTN15644451已完成未知
A multi-centred randomised controlled trial of an augmented exercise referral scheme using web-based behavioural support in individuals with metabolic, musculo-skeletal and mental health conditions
Plymouth University0 个研究点目标入组 450 人开始时间: 2015年2月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 450
研究概览
简要总结
2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33243368/ results (added 30/11/2020) 2018 Protocol article in https://pubmed.ncbi.nlm.nih.gov/30244214/ protocol (added 17/12/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33247001/ results (added 17/12/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36175996/ process evaluation (added 30/09/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 16/09/2016:
- •1. Aged 16-74 years
- •2. With one or more of the following:
- •2.1. Obesity (BMI 30-40)
- •2.2. Hypertension (Stage 1: SBP 140-159 or DBP 90-99; or Stage 2: SBP 160-179 or DBP 100-109)
- •2.3. Pre-diabetes
- •2.4 Type 2 diabetes
- •2.5. Lower limb osteoarthritis
- •2.6. Recent history of treatment for depression (i.e., last 2 years) but may not be currently receiving treatment
- •3. Participants who are in the follow two lowest (of four) groups identified using the GP Physical Activity Questionnaire recommended for use in the physical activity care pathway:
- •3.1. Inactive sedentary job and no physical exercise or cycling
- •3.2. Moderately inactive sedentary job and some but < 1 hour physical exercise and/or cycling per week OR standing job and no physical exercise
- •4. Have an e-mail address and at least some experience of using the internet
- •Previous inclusion criteria:
- •1. Aged 16-74 years
- •2. With one or more of the following:
- •2.1. Obesity (BMI 30-35)
- •2.2. Hypertension (Stage 1: SBP 140-159 or DBP 90-99; or Stage 2: SBP 160-179 or DBP 100-109)
- •2.3. Type 2 diabetes
- •2.4. Lower limb osteoarthritis
- •2.5. Recent history of treatment for depression (i.e., last 2 years) but may not be currently receiving treatment
- •3. Participants who are in the follow two lowest (of four) groups identified using the GP Physical Activity Questionnaire recommended for use in the PA Care Pathway:
- •3.1. Inactive sedentary job and no physical exercise or cycling
- •3.2. Moderately inactive sedentary job and some but < 1 hour physical exercise and/or cycling per week OR standing job and no physical exercise
- •4. Have an e-mail address and at least some experience of using the internet
排除标准
- •1. Unstable severe and enduring mental health problem that may limit involvement in the trial
- •2. Being treated for an alcohol problem or drug addiction
- •3. Inability to use written materials in English
- •4. Contra-indicated for moderate intensity PA
- •5. Have at least one medical condition that would exclude them from referral based on standard operating procedures for the ERS
研究者
相似试验
已完成
不适用
A multi-centre interventional study to determine patient and clinician impression of different compression therapy options for the treatment of poor leg circulatioChronic Venous InsufficiencyCirculatory SystemVenous insufficiency (chronic)(peripheral)ISRCTN95282887Cumbria Partnership NHS Foundation Trust44
进行中（未招募）
不适用
Scaphoid Waist Internal Fixation for Fractures Trial: A trial evaluating cast versus surgical fixation for fractures of the scaphoid waist in adultsMusculoskeletal trauma of the hand and wristMusculoskeletal DiseasesISRCTN67901257niversity Hospitals of Leicester NHS Trust (UK)439
已完成
不适用
nited Kingdom Frozen Shoulder Trial (UK FroST)Frozen shoulder (adhesive capsulitis)Musculoskeletal DiseasesAdhesive capsulitis of shoulderISRCTN48804508South Tees NHS Foundation Trust (UK)503
已完成
不适用
Cold oxygenated machine preservation of aged renal donation after cardiovascular death transplantsMachine perfusion preservation techniques of kidney graftsInjury, Occupational Diseases, PoisoningISRCTN32967929niversity of Oxford (UK)197
已完成
3 期
Vaccine Response On/off Methotrexate (VROOM): does temporarily suspending methotrexate treatment for two weeks enhance COVID-19 vaccine response?ISRCTN11442263CTU0373383